• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间变性淋巴瘤激酶的一种转录变体促进卵巢高级别浆液性癌的细胞凋亡。

A Transcriptional Variant of Anaplastic Lymphoma Kinase Promotes Apoptosis in Ovarian High-Grade Serous Carcinoma.

作者信息

Yokoi Ako, Yoshimori Daigo, Oguri Yasuko, Hashimura Miki, Saegusa Makoto

机构信息

Department of Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

出版信息

Mol Carcinog. 2025 May 19;64(8):1281-6. doi: 10.1002/mc.23928.

DOI:10.1002/mc.23928
PMID:40387841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12272811/
Abstract

The current study aims to delineate the role of a novel anaplastic lymphoma kinase (ALK) transcript, ALK, in ovarian high-grade serous carcinoma (HGSC). Overexpressed ALK exhibited both cytoplasmic and nuclear localization in HGSC cells, whereas full-length ALK was predominantly cytoplasmic. ALK interacts with the DNA repair protein, poly (ADP ribose) polymer 1 (PARP1), and cells stably overexpressing ALK (OE- ALK) were more sensitive to cisplatin-induced apoptosis. Consistent with this, cleaved PARP1 levels were higher in HGSC tissue samples in areas with nuclear ALK immunoreactivity. The ratio of antiapoptotic BCL2 relative to proapoptotic BAX was significantly increased in OE-ALK cells, despite the increase in apoptosis, suggesting that ALK-mediated apoptosis is independent of mitochondrion-driven cell death. OE-ALK decreased epithelial-mesenchymal transition/cancer stem cell properties but did not alter proliferation rates, and nuclear ALK immunopositivity was not associated with clinicopathological factors or prognosis in HGSC. Together, our observations suggest that ALK sensitizes HGSC cells to apoptosis (probably though an association with PARP1) but this may have a relatively minor impact on tumor progression.

摘要

本研究旨在阐明一种新型间变性淋巴瘤激酶(ALK)转录本ALK在卵巢高级别浆液性癌(HGSC)中的作用。过表达的ALK在HGSC细胞中表现出胞质和核定位,而全长ALK主要定位于胞质。ALK与DNA修复蛋白聚(ADP核糖)聚合酶1(PARP1)相互作用,稳定过表达ALK(OE-ALK)的细胞对顺铂诱导的凋亡更敏感。与此一致的是,在具有核ALK免疫反应性的HGSC组织样本区域中,裂解的PARP1水平更高。尽管凋亡增加,但在OE-ALK细胞中抗凋亡BCL2与促凋亡BAX的比率显著增加,这表明ALK介导的凋亡独立于线粒体驱动的细胞死亡。OE-ALK降低了上皮-间质转化/癌症干细胞特性,但未改变增殖率,并且核ALK免疫阳性与HGSC的临床病理因素或预后无关。总之,我们的观察结果表明,ALK使HGSC细胞对凋亡敏感(可能通过与PARP1相关),但这可能对肿瘤进展的影响相对较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/578ee4167fc8/MC-64-1281-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/2dabfca6ae7d/MC-64-1281-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/b73b89658f0c/MC-64-1281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/2a43afb5594a/MC-64-1281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/578ee4167fc8/MC-64-1281-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/2dabfca6ae7d/MC-64-1281-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/b73b89658f0c/MC-64-1281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/2a43afb5594a/MC-64-1281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6b/12272811/578ee4167fc8/MC-64-1281-g004.jpg

相似文献

1
A Transcriptional Variant of Anaplastic Lymphoma Kinase Promotes Apoptosis in Ovarian High-Grade Serous Carcinoma.间变性淋巴瘤激酶的一种转录变体促进卵巢高级别浆液性癌的细胞凋亡。
Mol Carcinog. 2025 May 19;64(8):1281-6. doi: 10.1002/mc.23928.
2
Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma.间变性淋巴瘤激酶过表达与卵巢高级别浆液性癌侵袭性表型特征相关。
Am J Pathol. 2021 Oct;191(10):1837-1850. doi: 10.1016/j.ajpath.2021.06.009. Epub 2021 Jun 29.
3
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.同时存在 RB1 缺失和 BRCA 缺陷可预测卵巢高级别浆液性管状癌的免疫反应增强和长期生存。
Clin Cancer Res. 2024 Aug 15;30(16):3481-3498. doi: 10.1158/1078-0432.CCR-23-3552.
4
CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.CST2 通过激活浆液性卵巢癌细胞中的 Wnt-β-连环蛋白信号通路促进细胞增殖并调节细胞周期。
J Obstet Gynaecol. 2024 Dec;44(1):2363515. doi: 10.1080/01443615.2024.2363515. Epub 2024 Jun 12.
5
Cancer Stem Cell-Related Marker NANOG Expression in Ovarian Serous Tumors: A Clinicopathological Study of 159 Cases.癌症干细胞相关标志物NANOG在卵巢浆液性肿瘤中的表达:159例临床病理研究
Int J Gynecol Cancer. 2017 Nov;27(9):2006-2013. doi: 10.1097/IGC.0000000000001105.
6
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.在输卵管卵巢高级别浆液性癌小鼠模型中,将细胞周期蛋白依赖性激酶12(CDK12)定义为一种肿瘤抑制因子和治疗靶点。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2426909122. doi: 10.1073/pnas.2426909122. Epub 2025 Jun 12.
7
Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals.高级别浆液性卵巢癌的基因组特征揭示了黑人个体独特的体细胞特征。
Cancer Res. 2025 May 2;85(9):1725-1737. doi: 10.1158/0008-5472.CAN-24-1879.
8
ADAMTS2 mediates epithelial‒mesenchymal transition and inflammation in high-grade serous ovarian cancer: a study based on bioinformatic analyses and experiments.ADAMTS2介导高级别浆液性卵巢癌的上皮-间质转化和炎症反应:一项基于生物信息学分析和实验的研究
BMC Cancer. 2025 Aug 26;25(1):1376. doi: 10.1186/s12885-025-14649-0.
9
Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells.奥洛昔唑通过促进 FOXO3a 核易位调节高级别浆液性卵巢癌(HGSOC)细胞的凋亡和细胞周期进程。
Mol Pharmacol. 2024 Aug 16;106(3):145-154. doi: 10.1124/molpharm.124.000921.
10
Pathogenesis of peritoneal high-grade serous carcinoma after risk-reducing surgery: a systematic review.降低风险手术后腹膜高级别浆液性癌的发病机制:一项系统综述
J Pathol Clin Res. 2025 Jul;11(4):e70037. doi: 10.1002/2056-4538.70037.

本文引用的文献

1
S100A4 contributes to colorectal carcinoma aggressive behavior and to chemoradiotherapy resistance in locally advanced rectal carcinoma.S100A4促进结直肠癌的侵袭性行为,并导致局部晚期直肠癌对放化疗产生耐药性。
Sci Rep. 2024 Dec 28;14(1):31338. doi: 10.1038/s41598-024-82814-9.
2
Genomic and experimental evidence that ALK does not predict single agent sensitivity to ALK inhibitors.基因组学和实验证据表明,ALK不能预测对ALK抑制剂的单药敏感性。
iScience. 2021 Oct 26;24(11):103343. doi: 10.1016/j.isci.2021.103343. eCollection 2021 Nov 19.
3
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
卵巢、输卵管及腹膜癌:2021年更新
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):61-85. doi: 10.1002/ijgo.13878.
4
Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma.间变性淋巴瘤激酶过表达与卵巢高级别浆液性癌侵袭性表型特征相关。
Am J Pathol. 2021 Oct;191(10):1837-1850. doi: 10.1016/j.ajpath.2021.06.009. Epub 2021 Jun 29.
5
ALK interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma.ALK 与 c-Myc 相互作用,促进肉瘤中的癌症干细胞样特性。
Oncogene. 2020 Jan;39(1):151-163. doi: 10.1038/s41388-019-0973-5. Epub 2019 Aug 28.
6
Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.间变性淋巴瘤激酶(ALK)受体酪氨酸激酶:一个具有多种面孔的催化受体。
Int J Mol Sci. 2018 Nov 2;19(11):3448. doi: 10.3390/ijms19113448.
7
Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma.鉴定LEFTY作为卵巢透明细胞癌的分子标志物。
Oncotarget. 2017 Jun 29;8(38):63646-63664. doi: 10.18632/oncotarget.18882. eCollection 2017 Sep 8.
8
Optimized p53 immunohistochemistry is an accurate predictor of mutation in ovarian carcinoma.优化的p53免疫组化是卵巢癌突变的准确预测指标。
J Pathol Clin Res. 2016 Jul 13;2(4):247-258. doi: 10.1002/cjp2.53. eCollection 2016 Oct.
9
The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma.化疗反应评分(CRS):一种简单且具有预后相关性的系统中观察者间的可重复性,用于报告输卵管卵巢高级别浆液性癌新辅助化疗的组织学反应
Int J Gynecol Pathol. 2017 Mar;36(2):172-179. doi: 10.1097/PGP.0000000000000307.
10
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.卵巢癌发生的二元模型:重新审视、修订与扩展
Am J Pathol. 2016 Apr;186(4):733-47. doi: 10.1016/j.ajpath.2015.11.011.